Literature DB >> 649303

Lysozyme levels in sarcoidosis.

J M Cummiskey, M Melinn, H McLaughlin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 649303     DOI: 10.1007/BF02939381

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  10 in total

1.  Photometric determination of lysozyme activity.

Authors:  G LITWACK
Journal:  Proc Soc Exp Biol Med       Date:  1955-07

2.  Plasma levels and the release of a lysozyme-like enzyme from tuberculin-exposed leukocytes of tuberculous and nontuberculous human beings.

Authors:  G P KERBY; S N CHAUDHURI
Journal:  J Lab Clin Med       Date:  1953-04

3.  Letter: Elevated muramidase levels in histiocytic medullary reticulosis.

Authors:  M Klockars; O Selroos
Journal:  N Engl J Med       Date:  1976-04-15       Impact factor: 91.245

4.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

Review 5.  The macrophage.

Authors:  S Gordon; Z A Cohn
Journal:  Int Rev Cytol       Date:  1973

6.  Serum lysozyme in pulmonary tuberculosis.

Authors:  P E Perillie; K Khan; S C Finch
Journal:  Am J Med Sci       Date:  1973-04       Impact factor: 2.378

7.  Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis.

Authors:  R S Pascual; J B Gee; S C Finch
Journal:  N Engl J Med       Date:  1973-11-15       Impact factor: 91.245

8.  Lysozyme in bone marrow and peripheral blood cells.

Authors:  R S Briggs; P E Perillie; S C Finch
Journal:  J Histochem Cytochem       Date:  1966-02       Impact factor: 2.479

9.  Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity.

Authors:  O Selroos; M Klockars
Journal:  Scand J Respir Dis       Date:  1977-04

10.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.